Men's Health News

RSS

Study shows only 44% of black males prefer to be investigated for prostate cancer

The incidence of prostate cancer among men of Afro-Caribbean origin is higher than in white men, they are more likely to be diagnosed as emergencies and their mortality rates are higher.

2 Mar 2015

Ninety percent of patients at risk of CHD fail to receive statins

The study, published in Current Medical Research and Opinion, provides the first ever real-world view of the treatment landscape for patients at risk of CHD[1], with a sample of two million patients. But the results paint a bleak picture of prescribing patterns with the majority not being given the potentially life saving drug.

27 Feb 2015

NICE recommends transurethral resection in saline system as the new gold standard for transurethral resection of the prostate

New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical’s transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.

From Evident Corporation - Life Sciences 27 Feb 2015

Life-saving bone marrow transplants are not available to all who need them

Bone marrow (hematopoietic stem cell) transplant is a life saving treatment for patients with blood cancer that replaces blood stem cells lost to disease or chemotherapy. However, for each patient to benefit a matching donor must be found to provide the stem cells for transplant.

27 Feb 2015

Loyola physician reveals top five health concerns for men, offers tips to prevent them

Men lead women in the likelihood to die from nearly all the most common causes of death. Still, men are less likely to go to the doctor than women and often try to ignore symptoms of health problems.

27 Feb 2015

Deadly C. difficile affected almost half a million in the U.S over one year

The deadly bug Clostridium difficile (C. diff) infected more than 450,000 people in the U.S in a single year, according to new research funded by the Centers for Disease Control and Prevention (CDC).

26 Feb 2015

Psoriasis management: an interview with Dr Sandy McBride

A major challenge around treating psoriasis is communication - psoriasis can flare and resolve in between appointments so it can be difficult to express and describe the life impact of these flares and recall possible triggers and response to treatments. People with psoriasis can also find it very difficult to talk about their emotions – something known as alexithymia – again making it difficult for clinicians to fully appreciate the impact of psoriasis.

25 Feb 2015

AR-V7 status does not affect response to taxane chemotherapy in patients with mCRPC

Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.

25 Feb 2015

PCF announces Challenge Awards to support research on new treatment strategies for prostate cancer

The Prostate Cancer Foundation (PCF) announces 3 new Challenge Awards to support discoveries for the treatment of lethal prostate cancer.

25 Feb 2015

Neurodegenerative disease research using NMR: an interview with Christian Griesinger

Christian Griesinger, director of the NMR-based Structural Biology department at the Max-Planck Institute for Biophysical Chemistry, talks about his research into neurodegenerative diseases using NMR to examine the dynamics of disordered proteins.

From Bruker BioSpin - NMR, EPR and Imaging 23 Feb 2015

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy

Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.

23 Feb 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.

21 Feb 2015

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.

20 Feb 2015

Ready to reconstitute BPW adds convenient option to support high throughput Salmonella testing in chocolate production

The discovery of Salmonella in one batch of a particular chocolate product, which prompted a recent recall, is a reminder of the importance of this pathogen in confectionery products.

20 Feb 2015

Scientists identify promising new therapeutic target for prostate cancer

Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.

20 Feb 2015

InflectraTM (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

Data have been presented today on the use of Hospira’s Inflectra (infliximab), the world’s first approved biosimilar monoclonal antibody (mAb), at the European Crohn’s and Colitis Organisation Inflammatory Bowel Diseases (ECCO-ibd) conference.

19 Feb 2015

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

Globally, dental caries (the technical term for tooth decay) is the most prevalent non-communicable disease, affecting 80% of the global population. Healthy teeth support overall well-being, while dental caries can contribute to high levels of pain and anxiety, as well as leading to other medical problems.

18 Feb 2015

The growing evidence on standardised packaging of tobacco products

The scientific journal Addiction has today published a collection of peer-reviewed research papers and commentaries that bring together key parts of the evidence base for standardised packaging of tobacco products from 2008 to 2015.

17 Feb 2015

Cabazitaxel therapy may be more effective in treating prostate cancer

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.

17 Feb 2015

Men's Health News

Study shows only 44% of black males prefer to be investigated for prostate cancer

Ninety percent of patients at risk of CHD fail to receive statins

NICE recommends transurethral resection in saline system as the new gold standard for transurethral resection of the prostate

Life-saving bone marrow transplants are not available to all who need them

Loyola physician reveals top five health concerns for men, offers tips to prevent them

Deadly C. difficile affected almost half a million in the U.S over one year

Psoriasis management: an interview with Dr Sandy McBride

AR-V7 status does not affect response to taxane chemotherapy in patients with mCRPC

PCF announces Challenge Awards to support research on new treatment strategies for prostate cancer

Neurodegenerative disease research using NMR: an interview with Christian Griesinger

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

MD Anderson awarded more than $22 million in research grants from CPRIT

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

Ready to reconstitute BPW adds convenient option to support high throughput Salmonella testing in chocolate production

Scientists identify promising new therapeutic target for prostate cancer

InflectraTM (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

The growing evidence on standardised packaging of tobacco products

Cabazitaxel therapy may be more effective in treating prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News